| Bioactivity | Rabacfosadine (GS-9219) succinate, a novel proagent of the nucleotide analogue PMEG, is designed as a cytotoxic agent that preferentially targets lymphoid cells[1]. |
| Name | Rabacfosadine succinate |
| CAS | 1431856-99-3 |
| Formula | C25H41N8O10P |
| Molar Mass | 644.61 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Reiser H, et al. GS-9219--a novel acyclic nucleotide analogue withpotent antineoplastic activity in dogs with spontaneous non-Hodgkin's lymphoma.Clin Cancer Res. 2008 May 1;14(9):2824-32. [2]. De Clercq E. Tanovea® for the treatment of lymphoma in dogs. Biochem Pharmacol. 2018 Aug;154:265-269. |
Rabacfosadine succinate
CAS: 1431856-99-3 F: C25H41N8O10P W: 644.61
Rabacfosadine (GS-9219) succinate, a novel proagent of the nucleotide analogue PMEG, is designed as a cytotoxic agent th
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.